T. Rowe Price Associates
INVA icon

T. Rowe Price Associates’s Innoviva INVA Stock Holding History

T. Rowe Price Associates’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19M Buy
93,940
+16,761
+22% +$361K ﹤0.01% 1789
2025
Q4 		$1.54M Buy
77,179
+4,722
+7% +$92.2K ﹤0.01% 1878
2025
Q3 		$1.32M Buy
72,457
+2,928
+4% +$57.1K ﹤0.01% 1936
2025
Q2 		$1.4M Sell
69,529
-8,799
-11% -$169K ﹤0.01% 1820
2025
Q1 		$1.42M Buy
78,328
+15,695
+25% +$281K ﹤0.01% 1773
2024
Q4 		$1.09M Buy
62,633
+6,927
+12% +$133K ﹤0.01% 1932
2024
Q3 		$1.08M Buy
55,706
+599
+1% +$11K ﹤0.01% 1941
2024
Q2 		$904K Buy
55,107
+3,620
+7% +$56.2K ﹤0.01% 1941
2024
Q1 		$785K Buy
51,487
+1,881
+4% +$29.5K ﹤0.01% 2016
2023
Q4 		$796K Buy
49,606
+1,360
+3% +$19K ﹤0.01% 1974
2023
Q3 		$627K Buy
48,246
+705
+1% +$9.15K ﹤0.01% 2002
2023
Q2 		$606K Buy
47,541
+1,243
+3% +$15.6K ﹤0.01% 2037
2023
Q1 		$521K Buy
46,298
+600
+1% +$7.28K ﹤0.01% 2086
2022
Q4 		$605K Buy
45,698
+1,133
+3% +$14.9K ﹤0.01% 2047
2022
Q3 		$518K Buy
44,565
+4,027
+10% +$55.2K ﹤0.01% 2108
2022
Q2 		$598K Buy
40,538
+2,200
+6% +$36K ﹤0.01% 2148
2022
Q1 		$742K Sell
38,338
-3,799
-9% -$67.9K ﹤0.01% 2160
2021
Q4 		$727K Sell
42,137
-627
-1% -$10.7K ﹤0.01% 2190
2021
Q3 		$715K Sell
42,764
-8,210
-16% -$123K ﹤0.01% 2205
2021
Q2 		$684K Sell
50,974
-11,892
-19% -$149K ﹤0.01% 2236
2021
Q1 		$751K Buy
62,866
+3,054
+5% +$36.9K ﹤0.01% 2184
2020
Q4 		$741K Sell
59,812
-381,593
-86% -$4.12M ﹤0.01% 2073
2020
Q3 		$4.61M Sell
441,405
-349,048
-44% -$4.44M ﹤0.01% 1410
2020
Q2 		$11.1M Sell
790,453
-10,931
-1% -$149K ﹤0.01% 1274
2020
Q1 		$9.42M Sell
801,384
-14,509
-2% -$192K ﹤0.01% 1242
2019
Q4 		$11.6M Buy
815,893
+22,475
+3% +$276K ﹤0.01% 1288
2019
Q3 		$8.36M Sell
793,418
-4,431
-0.6% -$53K ﹤0.01% 1316
2019
Q2 		$11.6M Sell
797,849
-221
-0% -$3.13K ﹤0.01% 1292
2019
Q1 		$11.2M Buy
798,070
+155,087
+24% +$2.51M ﹤0.01% 1302
2018
Q4 		$11.2M Buy
642,983
+116,107
+22% +$1.89M ﹤0.01% 1291
2018
Q3 		$8.03M Buy
526,876
+116,005
+28% +$1.67M ﹤0.01% 1406
2018
Q2 		$5.67M Buy
410,871
+34,482
+9% +$517K ﹤0.01% 1420
2018
Q1 		$6.27M Buy
376,389
+13,634
+4% +$210K ﹤0.01% 1402
2017
Q4 		$5.15M Buy
362,755
+36,546
+11% +$487K ﹤0.01% 1431
2017
Q3 		$4.61M Buy
326,209
+18,570
+6% +$246K ﹤0.01% 1448
2017
Q2 		$3.94M Sell
307,639
-3,529
-1% -$44.3K ﹤0.01% 1443
2017
Q1 		$4.3M Buy
311,168
+4,934
+2% +$58.1K ﹤0.01% 1443
2016
Q4 		$3.28M Sell
306,234
-163,300
-35% -$1.71M ﹤0.01% 1469
2016
Q3 		$5.16M Buy
469,534
+59,600
+15% +$696K ﹤0.01% 1423
2016
Q2 		$4.32M Buy
409,934
+900
+0.2% +$10.6K ﹤0.01% 1416
2016
Q1 		$5.15M Sell
409,034
-10,570
-3% -$116K ﹤0.01% 1394
2015
Q4 		$4.42M Sell
419,604
-11,590
-3% -$107K ﹤0.01% 1434
2015
Q3 		$3.1M Buy
431,194
+76,600
+22% +$1.04M ﹤0.01% 1498
2015
Q2 		$6.41M Buy
354,594
+16,930
+5% +$291K ﹤0.01% 1436
2015
Q1 		$5.31M Sell
337,664
-5,200
-2% -$78.7K ﹤0.01% 1464
2014
Q4 		$4.85M Sell
342,864
-21,330
-6% -$321K ﹤0.01% 1466
2014
Q3 		$6.22M Buy
364,194
+848
+0.2% +$19.5K ﹤0.01% 1420
2014
Q2 		$10.8M Sell
363,346
-76,414
-17% -$1.83M ﹤0.01% 1299
2014
Q1 		$11M Sell
439,760
-112,622
-20% -$3.3M ﹤0.01% 1279
2013
Q4 		$15.9M Sell
552,382
-1,951,484
-78% -$57.1M ﹤0.01% 1158
2013
Q3 		$82.5M Sell
2,503,866
-5,600,609
-69% -$174M 0.02% 647
2013
Q2 		$252M Buy
+8,104,475
New +$217M 0.07% 340

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's INVA Position: Q1 2026 in Review

T. Rowe Price Associates increased its Innoviva (INVA) stake by 22% in Q1 2026, buying an estimated $361K and bringing the position to 93,940 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

T. Rowe Price Associates first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $252M in Q2 2013. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • T. Rowe Price Associates held 93,940 shares of Innoviva worth $2.19M as of Q1 2026.
  • T. Rowe Price Associates bought 16,761 Innoviva shares in Q1 2026, an estimated $361K.
  • Innoviva made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1789 holding.
  • T. Rowe Price Associates first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Innoviva position peaked at $252M in Q2 2013.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.